Opiant Pharmaceuticals to Participate in 32nd Oppenheimer Healthcare Conference
March 10 2022 - 04:01PM
Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a
specialty pharmaceutical company developing medicines for
addictions and drug overdose, today announced that its Chief
Executive Officer, Dr. Roger Crystal, will participate in a
fireside chat at the 32nd Annual Oppenheimer Healthcare Conference
taking place virtually March 15 - March 17. Management will also
host investor 1x1 meetings.
32nd Oppenheimer Annual
Oppenheimer Healthcare ConferenceMarch 15 – 17,
2022Fireside chat on March 16 at 2:40 pm ET; hosting
1-on-1 meetings
A webcast of the presentation will be accessible on the
Opiant website.
About Opiant Pharmaceuticals,
Inc. Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose. For more information visit: www.opiant.com
and follow Opiant on Twitter (@Opiant_Pharma).
For Media and Investor Inquiries:Ben Atkins, Opiant(310)
598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Mar 2023 to Mar 2024